Cargando…

Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers

BACKGROUND: The clinical presentations of frontotemporal dementia (FTD) are diverse and overlap with other neurological disorders. There are, as of today, no biomarkers in clinical practice for diagnosing the disorders. Here, we aimed to find protein markers in cerebrospinal fluid (CSF) from patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Remnestål, Julia, Öijerstedt, Linn, Ullgren, Abbe, Olofsson, Jennie, Bergström, Sofia, Kultima, Kim, Ingelsson, Martin, Kilander, Lena, Uhlén, Mathias, Månberg, Anna, Graff, Caroline, Nilsson, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310563/ https://www.ncbi.nlm.nih.gov/pubmed/32576262 http://dx.doi.org/10.1186/s40035-020-00198-y

Ejemplares similares

A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study
por: Bergström, Sofia, et al.
Publicado: (2021)

TBK1 haploinsufficiency results in changes in the K63-ubiquitination profiles in brain and fibroblasts from affected and presymptomatic mutation carriers
por: Khoshnood, Behzad, et al.
Publicado: (2021)

Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds
por: Remnestål, Julia, et al.
Publicado: (2021)

CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease
por: Remnestål, Julia, et al.
Publicado: (2016)

Plasma metabolomics of presymptomatic PSEN1‐H163Y mutation carriers: a pilot study
por: Natarajan, Karthick, et al.
Publicado: (2021)

Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease
por: Bergström, Sofia, et al.
Publicado: (2021)

Altered plasma protein profiles in genetic FTD – a GENFI study
por: Ullgren, Abbe, et al.
Publicado: (2023)

CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers
por: Rostgaard, Nina, et al.
Publicado: (2018)

Presymptomatic cerebral blood flow changes in CHMP2B mutation carriers of familial frontotemporal dementia (FTD-3), measured with MRI
por: Lunau, Line, et al.
Publicado: (2012)

Disease-related cortical thinning in presymptomatic granulin mutation carriers
por: Borrego-Écija, Sergi, et al.
Publicado: (2020)

Gyrification abnormalities in presymptomatic c9orf72 expansion carriers
por: Caverzasi, Eduardo, et al.
Publicado: (2019)

FDG-PET in presymptomatic C9orf72 mutation carriers
por: Popuri, Karteek, et al.
Publicado: (2021)

Longitudinal Brain Atrophy Rates in Presymptomatic Carriers of Genetic Frontotemporal Dementia
por: Poos, Jackie M., et al.
Publicado: (2022)

Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers
por: Dorst, Johannes, et al.
Publicado: (2023)

Improved Differential Diagnosis of Alzheimer’s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers
por: Khoonsari, Payam Emami, et al.
Publicado: (2019)

Motor Decline in Clinically Presymptomatic Spinocerebellar Ataxia Type 2 Gene Carriers
por: Velázquez-Perez, Luis, et al.
Publicado: (2009)

Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers
por: Lee, Suzee E., et al.
Publicado: (2016)

Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients
por: Kim, Seong Eun, et al.
Publicado: (2020)

COVID-19 Transmission Within a Family Cluster by Presymptomatic Carriers in China
por: Qian, Guoqing, et al.
Publicado: (2020)

Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases
por: Braun, Madelene, et al.
Publicado: (2023)

Conformation-Dependent Oligomers in Cerebrospinal Fluid of Presymptomatic Familial Alzheimer's Disease Mutation Carriers
por: Ringman, John M., et al.
Publicado: (2012)

Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI
por: Feis, Rogier A., et al.
Publicado: (2018)

Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI
por: Feis, Rogier A., et al.
Publicado: (2019)

[(18)F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers
por: Wolters, Emma E., et al.
Publicado: (2021)

Eye movement alterations in presymptomatic C9orf72 expansion gene carriers
por: Behler, Anna, et al.
Publicado: (2021)

White-matter abnormalities in presymptomatic GRN and C9orf72 mutation carriers
por: Lee, Hyunwoo, et al.
Publicado: (2022)

Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers
por: Olm, Christopher A., et al.
Publicado: (2018)

Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers
por: Clarke, Mica T. M., et al.
Publicado: (2021)

The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD
por: Solje, Eino, et al.
Publicado: (2015)

Longitudinal changes in resting state networks in early presymptomatic carriers of C9orf72 expansions
por: Shoukry, Rachel Smallwood, et al.
Publicado: (2020)

Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion
por: De Vocht, Joke, et al.
Publicado: (2020)

An alternate prospect in detecting presymptomatic and asymptomatic COVID-19 carriers through odor differentiation by HeroRATs
por: Adekanmbi, Adejoke Joan, et al.
Publicado: (2021)

Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study()
por: Dopper, Elise G.P., et al.
Publicado: (2016)

Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers—a developmental disorder
por: Lulé, Dorothée E, et al.
Publicado: (2020)

Expression Profiling of Solute Carrier Gene Families at the Blood-CSF Barrier
por: Ho, Horace T. B., et al.
Publicado: (2012)

Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis
por: Thimm, Andreas, et al.
Publicado: (2023)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients
por: Chen, Yi, et al.
Publicado: (2021)

Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
por: Benatar, Michael, et al.
Publicado: (2022)

Factors associated with healthcare utilisation during first year after cancer diagnose—a population‐based study
por: Ullgren, Helena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fgkhu5l9v5volb7tc90i60jj1v